By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A trio of Vermillion shareholders have notified the firm that they intend to nominate two people for election to the board of directors as they seek to replace Gail Page and John Hamilton.

Page is Vermillion's president and CEO, and Hamilton is a former VP and CFO of Depomed but is not an executive of the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.